NCT02502058

Brief Summary

The primary objective of this study is to determine if the use of a bone compaction process (osseodensification) (Densah™ bur: Versah Osseodensification Company™) to prepare dental implant sites, in human subjects, results in increased bone-ridge width, increased compact bone in the outer wall of the prepared sites, and dental implant stability.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

July 10, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 17, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

June 20, 2017

Status Verified

June 1, 2017

Enrollment Period

1.7 years

First QC Date

July 10, 2015

Last Update Submit

June 16, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone-ridge width before and immediately after preparation of the implant site when using the Densah Bur.

    The width of the bony ridge into which the dental implant will be placed will be measured immediately before drilling the opening with the Densah Bur and then again following completion of drilling but before the dental implant is placed into the prepared opening. These measurements will occur at the time of the implant surgery.

    intraoperative

Secondary Outcomes (2)

  • insertion torque value (ITV)

    intraoperative

  • implant stability quotient (ISQ)

    intraoperative , at 3 weeks and 6 weeks post surgery

Interventions

Densah™ bur (Versah Osseodensification Company™) is used to prepare dental implant sites, in human subjects, by compacting (osseodensification ) bone vs. removing bone to create the opening in the jaw bone into which the dental implant is then placed. This osseodensification process results in increased bone-ridge width, increased compact bone in the outer wall of the prepared sites, and; it is believed, increases implant stability.

Also known as: Versah Osseodensification Company™

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study subjects will include 40 healthy adult patients who seek dental implant placement to replace missing teeth in their mouths.

You may qualify if:

  • Males and females
  • Ages 18-80 years of age
  • Missing at least one tooth.
  • Capable of giving informed consent

You may not qualify if:

  • Patient is a pregnant female
  • Patient smoking more than 5 cigarettes per day
  • Patient has a history of alcoholism or drug abuse during the last 5 years
  • Patient with uncontrolled hypertension or diabetes
  • Patient has a malignant tumor
  • Patient is on daily dose of steroids
  • Patient with history of chemotherapy or radiation for the last 12 months
  • Patient who is immuno suppressed
  • Patient with titanium allergy
  • Subject should not be a homeless person

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oral Health Research Clinic at the School of Dentistry at the University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

Related Links

MeSH Terms

Conditions

Anodontia

Condition Hierarchy (Ancestors)

Tooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Patricia A Lenton, MA

    University of Minnesota

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2015

First Posted

July 17, 2015

Study Start

July 1, 2015

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

June 20, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

No plan to share study data.

Locations